• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

uPARAP/endo180引导IV型胶原蛋白向溶酶体的转运及降解。

uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV.

作者信息

Kjøller Lars, Engelholm Lars H, Høyer-Hansen Maria, Danø Keld, Bugge Thomas H, Behrendt Niels

机构信息

Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

出版信息

Exp Cell Res. 2004 Feb 1;293(1):106-16. doi: 10.1016/j.yexcr.2003.10.008.

DOI:10.1016/j.yexcr.2003.10.008
PMID:14729061
Abstract

Collagen turnover is crucial for tissue homeostasis and remodeling and pathological processes such as cancer invasion, but the underlying molecular mechanisms are poorly understood. A major pathway appears to be internalization and degradation by fibroblasts. We now show that the endocytic transmembrane glycoprotein urokinase plasminogen activator receptor-associated protein (uPARAP/endo180) directs collagen IV for lysosomal delivery and degradation. In wild-type fibroblasts, fluorescently labeled collagen IV was first internalized into vesicular structures with diffuse fluorescence eventually appearing uniformly within the wild-type cells after longer incubation times. In these cells, some collagen-containing vesicles were identified as lysosomes by staining for LAMP-1. In contrast, collagen IV remained extracellular and associated with fiber-like structures on uPARAP/endo180-deficient fibroblasts. Blocking lysosomal cysteine proteases with the inhibitor E64d resulted in strong accumulation of collagen IV in lysosomes in wild-type cells, but only very weak intracellular fluorescence accumulation in uPARAP/endo180-deficient fibroblasts. We conclude that uPARAP/endo180 is critical for targeted delivery of collagen IV to lysosomes for degradation implicating the receptor in normal and malignant extracellular matrix degradation. A similar localization pattern was observed for collagen V, suggesting that uPARAP/endo180 might be generally involved in collagen degradation.

摘要

胶原蛋白周转对于组织稳态、重塑以及诸如癌症侵袭等病理过程至关重要,但其潜在的分子机制仍知之甚少。一条主要途径似乎是成纤维细胞的内化和降解。我们现在表明,内吞跨膜糖蛋白尿激酶型纤溶酶原激活物受体相关蛋白(uPARAP/endo180)引导IV型胶原蛋白进行溶酶体递送和降解。在野生型成纤维细胞中,荧光标记的IV型胶原蛋白首先被内吞到具有弥漫性荧光的囊泡结构中,在较长孵育时间后最终在野生型细胞内均匀出现。在这些细胞中,一些含有胶原蛋白的囊泡通过溶酶体相关膜蛋白1(LAMP-1)染色被鉴定为溶酶体。相比之下,IV型胶原蛋白在uPARAP/endo180缺陷型成纤维细胞中仍位于细胞外并与纤维状结构相关。用抑制剂E64d阻断溶酶体半胱氨酸蛋白酶会导致野生型细胞中IV型胶原蛋白在溶酶体中大量积累,但在uPARAP/endo180缺陷型成纤维细胞中细胞内荧光积累非常微弱。我们得出结论,uPARAP/endo180对于将IV型胶原蛋白靶向递送至溶酶体进行降解至关重要,这表明该受体参与正常和恶性细胞外基质降解。对于V型胶原蛋白观察到类似的定位模式,表明uPARAP/endo180可能普遍参与胶原蛋白降解。

相似文献

1
uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV.uPARAP/endo180引导IV型胶原蛋白向溶酶体的转运及降解。
Exp Cell Res. 2004 Feb 1;293(1):106-16. doi: 10.1016/j.yexcr.2003.10.008.
2
A novel functional role of collagen glycosylation: interaction with the endocytic collagen receptor uparap/ENDO180.胶原糖基化的新功能作用:与内吞胶原受体 uparap/ENDO180 的相互作用。
J Biol Chem. 2011 Sep 16;286(37):32736-48. doi: 10.1074/jbc.M111.266692. Epub 2011 Jul 18.
3
uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion.uPARAP/Endo180对于细胞摄取胶原蛋白至关重要,并促进成纤维细胞胶原蛋白黏附。
J Cell Biol. 2003 Mar 31;160(7):1009-15. doi: 10.1083/jcb.200211091.
4
Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.由uPARAP/Endo180介导的细胞内胶原蛋白降解是恶性肿瘤期间细胞外基质周转的主要途径。
J Cell Biol. 2005 Jun 20;169(6):977-85. doi: 10.1083/jcb.200411153.
5
Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis.内吞胶原降解:一种新的抗肝纤维化机制。
J Pathol. 2012 May;227(1):94-105. doi: 10.1002/path.3981. Epub 2012 Feb 17.
6
The non-phagocytic route of collagen uptake: a distinct degradation pathway.非吞噬途径摄取胶原蛋白:一种独特的降解途径。
J Biol Chem. 2011 Jul 29;286(30):26996-7010. doi: 10.1074/jbc.M110.208033. Epub 2011 Jun 7.
7
Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180.变性胶原蛋白被肝星状细胞摄取:尿激酶型纤溶酶原激活物受体相关蛋白/Endo180参与的证据
Biochem J. 2005 Apr 1;387(Pt 1):39-46. doi: 10.1042/BJ20040966.
8
Phagocytosis of Collagen Fibrils by Fibroblasts In Vivo Is Independent of the uPARAP/Endo180 Receptor.成纤维细胞在体内对胶原纤维的吞噬作用不依赖于uPARAP/Endo180受体。
J Cell Biochem. 2017 Jun;118(6):1590-1595. doi: 10.1002/jcb.25821. Epub 2017 Jan 11.
9
Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation.细胞外胶原酶与内吞受体尿激酶型纤溶酶原激活物受体相关蛋白/Endo180协同作用,参与成纤维细胞介导的胶原降解。
J Biol Chem. 2007 Sep 14;282(37):27037-27045. doi: 10.1074/jbc.M701088200. Epub 2007 Jul 9.
10
The collagen receptor uPARAP/Endo180.胶原蛋白受体uPARAP/Endo180。
Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2103-14. doi: 10.2741/3365.

引用本文的文献

1
The life cycle of type IV collagen.IV型胶原蛋白的生命周期。
Matrix Biol. 2025 Aug;139:14-28. doi: 10.1016/j.matbio.2025.04.004. Epub 2025 Apr 28.
2
Novel kinase regulators of extracellular matrix internalisation identified by high-content screening modulate invasive carcinoma cell migration.通过高内涵筛选鉴定出的新型细胞外基质内化激酶调节剂可调节侵袭性癌细胞迁移。
PLoS Biol. 2024 Dec 12;22(12):e3002930. doi: 10.1371/journal.pbio.3002930. eCollection 2024 Dec.
3
Rare Variant in Associated With Familial Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome.
与家族性室上性心动过速和预激综合征相关的罕见变异。
Circ Genom Precis Med. 2024 Aug;17(4):e004614. doi: 10.1161/CIRCGEN.124.004614. Epub 2024 Jul 2.
4
The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism.细胞外基质通过促进酪氨酸分解代谢来支持氨基酸饥饿状态下的乳腺癌细胞生长。
PLoS Biol. 2024 Jan 16;22(1):e3002406. doi: 10.1371/journal.pbio.3002406. eCollection 2024 Jan.
5
Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma.Endo180(MRC2)抗体药物偶联物治疗肉瘤。
Mol Cancer Ther. 2023 Feb 1;22(2):240-253. doi: 10.1158/1535-7163.MCT-22-0312.
6
Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch.PLA2R 结构揭示了主要膜性肾病表位和免疫原性斑块的呈现。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2202209119. doi: 10.1073/pnas.2202209119. Epub 2022 Jul 11.
7
uPARAP/Endo180: a multifaceted protein of mesenchymal cells.uPARAP/Endo180:间充质细胞的多功能蛋白。
Cell Mol Life Sci. 2022 Apr 22;79(5):255. doi: 10.1007/s00018-022-04249-7.
8
Immune Modulatory Properties of Collagen in Cancer.胶原蛋白在癌症中的免疫调节特性。
Front Immunol. 2021 Dec 8;12:791453. doi: 10.3389/fimmu.2021.791453. eCollection 2021.
9
Antibody Conjugates for Sarcoma Therapy: How Far along Are We?用于肉瘤治疗的抗体偶联物:我们进展到什么程度了?
Biomedicines. 2021 Aug 8;9(8):978. doi: 10.3390/biomedicines9080978.
10
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.特定的癌相关成纤维细胞群体的损伤限制了肿瘤生长和转移。
Nat Commun. 2021 Jun 10;12(1):3516. doi: 10.1038/s41467-021-23583-1.